Medicine Information

New Antidepressant Developments and Approvals


New antidepressant development, until fairly recently, was at best a random, and at worst a problematic and frustrating, process. Often, medications that were developed for one thing were discovered quite accidentally to have much more important therapeutic effects for a completely different disorder. It has been well described that some of the original antipsychotics were originally developed to assist in anesthesia, and some of the original new antidepressants were originally intended to be medications for tuberculosis or psychosis. New antidepressant development was done on a "chemical" basis; that is, guesses were made as to compounds that would be safe and effective based on chemical structures of established medications. This was very much a trial-and-error process, since very little was known about how these drugs worked and very little could be measured beyond actually giving them to a patient.

New antidepressant development always has been and always will be a partnership between efficacy (ie, whether the drug is effective) and safety (ie, whether the drug can be tolerated by a patient). There were very few ways of knowing the answers to those two questions about any given compound unless you tried it, a process not without its obvious risks. It should be noted that vagus nerve stimulation for depression clearly meets the two main FDA requirements of safety and efficacy.

Medications to treat depression; mild, severe, bipolar, or treatment-resistant, make the news most frequently, and deservedly so. Their progress and approval can potentially benefit almost 8 million Americans who suffer from some form of depression. Because there seems to be more frequency now of depression that is treatment-resistant, meaning most methods of treatment (medications, psychotherapy, electroconvulsive therapy, or a combination of more than one treatment) have failed for a patient, the approval of new antidepressants from companies like Merck, Lilly, and Pfizer, are more important than ever. This is because a new class of medication for treating depression has not been developed in over a decade.

On July 18th, 2005 the FDA approved the first ever treatment long term treatment option for depression; vagus nerve stimulation. You can learn more about this remarkable treatment at http://www.VagusNerveStimulator.com There is a free electronic newsletter to keep you up-to-date.

Charles Donovan was a patient in the FDA investigational trial of vagus nerve stimulation as a treatment for chronic or recurrent treatment-resistant depression. He was implanted with the vagus nerve stimulator in April of 2001. He chronicles his journey from the grips of depression thanks to vagus nerve stimulation therapy in his book:

Out of the Black Hole: The Patient's Guide to Vagus Nerve Stimulation and Depression

The book was exhibited at the American Psychiatric Association's Annual Meeting in May. It is available on his web site and 24 hours a day/7 days a week through the toll free number 1-888-VAGUS-88. If you use discount code FDAYES(all caps), it will save you 25% off the cost of the book and you will get automatic free shipping via U.S. Postal Priority Mail.

The book is also available through Amazon.com and Barnes & Noble.com. The discount does not apply at these two sites.

He is the founder of the http://www.VagusNerveStimulator.com Web Site


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


Salt Lake Tribune

Commentary: The Tribune was wrong. Medicine often involves a risk to the patient.
Salt Lake Tribune
(Courtesy of the Utah Department of Health) A health department initiative called Talk to Your Pharmacist placed stickers on bottles to prompt prescribers to talk to their pharmacist about the risk of using opioids. By Lynn Webster | For The Tribune ...



The Guardian

Adam Kay: 'If I had kids I would put them off studying medicine'
The Guardian
Kay had enjoyed a longstanding interest in comedy, performing in medical student revues, and later in corporate gigs for pharmaceutical companies. He'd also been on Radio 4 and performed at the Edinburgh festival, so comedy was the obvious way to go ...



Florida Flambeau

FSU College of Medicine hosts World AIDS Day vigil
Florida Flambeau
From 2008 to 2010, there were about 32 new HIV cases and 19 new AIDS cases in Leon County. During this time period, Leon County reported 1,392 cases of gonorrhea, chlamydia and syphilis. Gonorrhea and syphilis rates are higher in this county than ...

and more »


The Hindu

'Exciting careers beyond engineering and medicine'
The Hindu
In a State where a huge chunk of student population go towards engineering and medicine, choosing a course other than the two requires a certain aptitude. It's the aptitude that matters when choosing a career, experts from various fields advised ...



New York Times

What Doctors Should Ignore
New York Times
Those variants are enriched in people of African ancestry. Girish N. Nadkarni, a kidney specialist at Icahn School of Medicine at Mount Sinai in New York City, explained to me that scientists think this may be because those variants protect against the ...



KFSN-TV

New Treatment for Neuropathy: Medicine's Next Big Thing?
KFSN-TV
Thirty percent of all Americans will be affected by peripheral neuropathy, a condition that impacts nerves leading to the arms and legs. (KFSN). KFSN. By Margot Kim. Saturday, December 09, 2017 11:48PM. Thirty percent of all Americans will be affected ...



Rethink Healthcare: Government hospitals must provide quality, affordable medicine
Economic Times (blog)
Delhi government's decision to cancel the licence of Max hospital, Shalimar Bagh, for negligence resulting in the death of a premature newborn – the baby was declared dead by the hospital even though he was alive at the time he was given to his parents ...

and more »


Daily Mail

HEALTH: Nature's medicine for sore joints
Daily Mail
When financier John Carey, then 35, woke up one night in 2002 with a searing pain in the ball of his left foot, the last thing on his mind was gout. 'I'd been training hard the day before – I practise judo and ran marathons – and thought I must have ...



HuffPost

Medicine And Why Net Neutrality Matters
HuffPost
Recently, the library at Einstein, where I work as a medical librarian, experienced a momentary internet outage. In that instant, everything seemed to stop in its tracks. Medical students preparing to take their STEP 1 Board exams couldn't finish their ...

and more »


EurekAlert (press release)

Landmark CAR-T cancer study published in the New England Journal of Medicine
EurekAlert (press release)
IMAGE: This is how CAR-T cell therapy harnesses a patient's immune system to fight cancer. view more. Credit: Loyola Medicine. MAYWOOD, IL - Loyola University Medical Center is the only Chicago center that participated in the pivotal clinical trial of ...
Loyola Medicine Oncologist Patrick Stiff, MD, Co-Author of Landmark @NEJM CAR-T Study, Offers Measured ...Newswise (press release)

all 7 news articles »

Google News

home | site map | Dr. Thad Thomas
© 2006